3-[3-(Chloromethyl)-1,2,4-oxadiazol-5-yl]-2-(methylsulfanyl)pyridine → HCID 24984458, compound
Reaction equation
[F:1][C:2]([F:15])([F:14])[C:3]1[C:11]([C:12]#[N:13])=[CH:10][CH:9]=[C:8]2[C:4]=1[CH:5]=[CH:6][NH:7]2.Cl[CH2:17][C:18]1[N:22]=[C:21]([C:23]2[C:24]([S:29][CH3:30])=[N:25][CH:26]=[CH:27][CH:28]=2)[O:20][N:19]=1>>[CH3:30][S:29][C:24]1[C:23]([C:21]2[O:20][N:19]=[C:18]([CH2:17][N:7]3[C:8]4[C:4](=[C:3]([C:2]([F:14])([F:1])[F:15])[C:11]([C:12]#[N:13])=[CH:10][CH:9]=4)[CH:5]=[CH:6]3)[N:22]=2)=[CH:28][CH:27]=[CH:26][N:25]=1Participants
3
Procedure
Synthesized as described in Example 23 using 4-(trifluoromethyl)-1H-indole-5-carbonitrile and 3-[3-(chloromethyl)-1,2,4-oxadiazol-5-yl]-2-(methylthio)pyridine: MS (ES) m/z 416 (M+1).
Workup
- customSynthesized
Sources & evidence
- ORD record
- ord-d8be210fa9dc43278513cdabda1852a3
- Source dataset
- uspto-grants-2009_08
- Patent number
- US07572820B2
Reaction notes
Loading…